Evidence map›Paper›PMID 32015948›Full record

Article3 Biotech2020

Impact of fecal microbiota transplantation on TGF-β1/Smads/ERK signaling pathway of endotoxic acute lung injury in rats.

Bo Li, Guo-Fang Yin, Yu-Lei Wang, Yi-Ming Tan, Cheng-Liang Huang, Xian-Ming Fan

Open access · bronzeAbstract read
In one paragraph

Article in 3 Biotech, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Roles of the gut microbiota in severe SARS-CoV-2 infection.Cytokine & growth factor reviews · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Bo LiThe Department of Respiratory and Critical Care Medicine II, Affiliated Hospital of Southwest Medical University, Luzhou, 646000 SiChuan China.
Guo-Fang YinThe Department of Respiratory and Critical Care Medicine II, Affiliated Hospital of Southwest Medical University, Luzhou, 646000 SiChuan China.
Yu-Lei WangThe Department of Respiratory and Critical Care Medicine II, Affiliated Hospital of Southwest Medical University, Luzhou, 646000 SiChuan China.
Yi-Ming TanThe Department of Respiratory and Critical Care Medicine II, Affiliated Hospital of Southwest Medical University, Luzhou, 646000 SiChuan China.
Cheng-Liang HuangThe Department of Respiratory and Critical Care Medicine II, Affiliated Hospital of Southwest Medical University, Luzhou, 646000 SiChuan China.
Xian-Ming FanThe Department of Respiratory and Critical Care Medicine II, Affiliated Hospital of Southwest Medical University, Luzhou, 646000 SiChuan China.ORCID 0000-0003-2604-0847
Affiliated Hospital of Southwest Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute lung injury (ALI) is a common clinical disease with high morbidity in both humans and animals. Studies have shown that intestinal microbiota affect the pathology and immune function of respiratory diseases through the "gut-lung axis". The authors investigated the therapeutic effect of fecal microbiota transplantation (FMT) in rats with ALI induced by lipopolysaccharide (LPS). Rats were treated with FMT, and then measured lung wet/dry ratio, PaO

Indexed as

Acute lung injuryEndotoxicFecal microbiota transplantationHigh-throughput sequencingIntestinal microbiotaLipopolysaccharide

Identifiers

PMID32015948
PMCPMC6971213
OpenAlexW3002665570

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.